Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA five-year strategic priorities
You may also be interested in...
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.